drugset / Trial / NCT00739635

Efficacy, Safety and Tolerability of Neramexane in Patients With Subjective Tinnitus

NCT00739635 ↗

Phase 3 Completed 411 enrolled Merz Pharmaceuticals GmbH
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to investigate the safety and efficacy of neramexane mesylate in the treatment of subjective tinnitus in comparison to placebo.

Timeline

Start
2008-09
Primary completion
2010-02
Completion
2010-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Neramexane Small molecule 75 mg —

Indications